Categories AlphaGraphs, Earnings, Health Care

Earnings Summary: Highlights of Humana’s Q2 2024 report

Humana Inc. (NYSE: HUM), a leading health and well-being company, reported a decrease in adjusted earnings for the second quarter of 2024 when its revenues grew in double digits.

  • Second-quarter earnings, on an adjusted basis, dropped to $6.96 per share from $8.94 per share in the prior-year quarter
  • Including special items, Q2 net income came in at $5.62 per share, vs. $7.66 per share in the same period last year
  • June quarter revenues increased to $29.54 billion from $26.75 billion in the year-ago quarter
  • The management revised its FY2024 EPS guidance, on a reported basis, to about $12.81 from the previous forecast of $13.93
  • The company affirmed its full-year adjusted earnings guidance at $16.00 per share, and the Insurance segment benefit ratio at around 90%
  • As of June 30, 2024, days in claims payable was 41.6 days, which represents a decrease of 0.9 day from March 31, 2024

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Earnings Preview: FedEx looks set to report mixed results for Q4 2025

FedEx Corp. (NYSE: FDX) is preparing to report fourth-quarter earnings on Tuesday, June 24, at 4:00 pm ET. Recently, the management lowered its full-year earnings and revenue guidance for the

How Ulta Beauty’s (ULTA) new strategy is fueling growth

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) were up over 1% on Monday. The stock has gained 31% over the past three months. The beauty retailer started fiscal year 2025

Earnings Preview: What to look for when Kroger (KR) reports Q1 2025 results

The Kroger Co. (NYSE: KR) is expected to report its first-quarter financial results next week. Customer engagement remained stable last year, driven by high-quality products and tailored promotional offers. Recently,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top